Quinone-amino acid conjugates targeting Leishmania amino acid transporters.
The aim of the present study was to investigate the feasibility of targeting Leishmania transporters via appropriately designed chemical probes. Leishmania donovani, the parasite that causes visceral leishmaniasis, is auxotrophic for arginine and lysine and has specific transporters (LdAAP3 and LdAA...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4177859?pdf=render |
id |
doaj-8bda84fcf4d34064b48248a8606c7a18 |
---|---|
record_format |
Article |
spelling |
doaj-8bda84fcf4d34064b48248a8606c7a182020-11-25T01:52:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10799410.1371/journal.pone.0107994Quinone-amino acid conjugates targeting Leishmania amino acid transporters.Federica PratiAdele Goldman-PinkovichFederica LizziFederica BellutiRoni KorenDan ZilbersteinMaria Laura BolognesiThe aim of the present study was to investigate the feasibility of targeting Leishmania transporters via appropriately designed chemical probes. Leishmania donovani, the parasite that causes visceral leishmaniasis, is auxotrophic for arginine and lysine and has specific transporters (LdAAP3 and LdAAP7) to import these nutrients. Probes 1-15 were originated by conjugating cytotoxic quinone fragments (II and III) with amino acids (i.e. arginine and lysine) by means of an amide linkage. The toxicity of the synthesized conjugates against Leishmania extracellular (promastigotes) and intracellular (amastigotes) forms was investigated, as well their inhibition of the relevant amino acid transporters. We observed that some conjugates indeed displayed toxicity against the parasites; in particular, 7 was identified as the most potent derivative (at concentrations of 1 µg/mL and 2.5 µg/mL residual cell viability was reduced to 15% and 48% in promastigotes and amastigotes, respectively). Notably, 6, while retaining the cytotoxic activity of quinone II, displayed no toxicity against mammalian THP1 cells. Transport assays indicated that the novel conjugates inhibited transport activity of lysine, arginine and proline transporters. Furthermore, our analyses suggested that the toxic conjugates might be translocated by the transporters into the cells. The non-toxic probes that inhibited transport competed with the natural substrates for binding to the transporters without being translocated. Thus, it is likely that 6, by exploiting amino acid transporters, can selectively deliver its toxic effects to Leishmania cells. This work provides the first evidence that amino acid transporters of the human pathogen Leishmania might be modulated by small molecules, and warrants their further investigation from drug discovery and chemical biology perspectives.http://europepmc.org/articles/PMC4177859?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Federica Prati Adele Goldman-Pinkovich Federica Lizzi Federica Belluti Roni Koren Dan Zilberstein Maria Laura Bolognesi |
spellingShingle |
Federica Prati Adele Goldman-Pinkovich Federica Lizzi Federica Belluti Roni Koren Dan Zilberstein Maria Laura Bolognesi Quinone-amino acid conjugates targeting Leishmania amino acid transporters. PLoS ONE |
author_facet |
Federica Prati Adele Goldman-Pinkovich Federica Lizzi Federica Belluti Roni Koren Dan Zilberstein Maria Laura Bolognesi |
author_sort |
Federica Prati |
title |
Quinone-amino acid conjugates targeting Leishmania amino acid transporters. |
title_short |
Quinone-amino acid conjugates targeting Leishmania amino acid transporters. |
title_full |
Quinone-amino acid conjugates targeting Leishmania amino acid transporters. |
title_fullStr |
Quinone-amino acid conjugates targeting Leishmania amino acid transporters. |
title_full_unstemmed |
Quinone-amino acid conjugates targeting Leishmania amino acid transporters. |
title_sort |
quinone-amino acid conjugates targeting leishmania amino acid transporters. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
The aim of the present study was to investigate the feasibility of targeting Leishmania transporters via appropriately designed chemical probes. Leishmania donovani, the parasite that causes visceral leishmaniasis, is auxotrophic for arginine and lysine and has specific transporters (LdAAP3 and LdAAP7) to import these nutrients. Probes 1-15 were originated by conjugating cytotoxic quinone fragments (II and III) with amino acids (i.e. arginine and lysine) by means of an amide linkage. The toxicity of the synthesized conjugates against Leishmania extracellular (promastigotes) and intracellular (amastigotes) forms was investigated, as well their inhibition of the relevant amino acid transporters. We observed that some conjugates indeed displayed toxicity against the parasites; in particular, 7 was identified as the most potent derivative (at concentrations of 1 µg/mL and 2.5 µg/mL residual cell viability was reduced to 15% and 48% in promastigotes and amastigotes, respectively). Notably, 6, while retaining the cytotoxic activity of quinone II, displayed no toxicity against mammalian THP1 cells. Transport assays indicated that the novel conjugates inhibited transport activity of lysine, arginine and proline transporters. Furthermore, our analyses suggested that the toxic conjugates might be translocated by the transporters into the cells. The non-toxic probes that inhibited transport competed with the natural substrates for binding to the transporters without being translocated. Thus, it is likely that 6, by exploiting amino acid transporters, can selectively deliver its toxic effects to Leishmania cells. This work provides the first evidence that amino acid transporters of the human pathogen Leishmania might be modulated by small molecules, and warrants their further investigation from drug discovery and chemical biology perspectives. |
url |
http://europepmc.org/articles/PMC4177859?pdf=render |
work_keys_str_mv |
AT federicaprati quinoneaminoacidconjugatestargetingleishmaniaaminoacidtransporters AT adelegoldmanpinkovich quinoneaminoacidconjugatestargetingleishmaniaaminoacidtransporters AT federicalizzi quinoneaminoacidconjugatestargetingleishmaniaaminoacidtransporters AT federicabelluti quinoneaminoacidconjugatestargetingleishmaniaaminoacidtransporters AT ronikoren quinoneaminoacidconjugatestargetingleishmaniaaminoacidtransporters AT danzilberstein quinoneaminoacidconjugatestargetingleishmaniaaminoacidtransporters AT marialaurabolognesi quinoneaminoacidconjugatestargetingleishmaniaaminoacidtransporters |
_version_ |
1724992180094763008 |